Universe Pharmaceuticals is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacture and sale of traditional Chinese medicine derivative (TCDM) products targeted to the elderly to address their physical conditions in the aging process and to promote their general well-being. In addition, Co. also sells biochemical drugs, medical instruments, Traditional Chinese Medicine Pieces products and dietary supplements manufactured by third-party pharmaceutical companies. TCMD products has two categories: treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity; and cold and flu medications. The UPC stock yearly return is shown above.
The yearly return on the UPC stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the UPC annual return calculation with any dividends reinvested as applicable (on ex-dates).
|